Physicians

The materials were developed for clinicians to use with patients while discussing the 12-dose regimen for the treatment of latent TB infection. The materials include a patient education brochure, medication tracker, and symptom checklist. The brochure contains information on latent TB infection, the 12-dose regimen, and adverse events. The medication tracker includes space to write treatment schedules, medication intake, and doctor/clinic contact information. There is also a checklist of signs and symptoms that may develop while using the 12-dose regimen.

Speakers for this webinar include the Deputy Director of the Global TB Institute and a survivor of MDR-TB. By the end of the webinar, participants will be able to: define stigma in the context of tuberculosis prevention and care, describe how stigma affects persons with tuberculosis, and apply interventions in the health care setting and community to reduce stigma.

This one-page flow diagram for clinicians and health-care providers lists remarks and side effects of second-line drugs used to treat MDR-TB. It provides information on the measured MIC, serum levels, and dosing of each drug.

This video presents information on the difference between TB infection and disease, testing methods and recommendations, and interpretation of test results. The video also discusses special considerations for testing and the medical evaluation process.

The video contains information on the basics of TB infection, targeted testing, recommendations for screening and testing high-risk groups, and patient education messages.

The tool shows sample reactions to the Mantoux tuberculin skin test and includes a card with descriptions of each reaction. The product is $330, which includes one arm, one base, and shipping.

Total cost of $330 includes one arm, one base, and shipping. Also included is a laminated card that provides full descriptions of each reaction.

Available in light, medium, and dark skin tone please make a skin tone selection before you add this item to your cart.

This information card provides information on the multiple significant drug interactions between TB medications; specifically, INH, rifampin, and other medications and the effect of the interaction. It also provides information on food interactions with TB drugs.

This fact sheet provides information on tuberculin skin testing. It explains how to interpret tuberculin skin test (TST) results, including special considerations. 

This pocket-sized card for clinicians provides information on identifying those at risk for TB. The resource also includes content on latent TB infection testing, diagnosis, and treatment in adults. 

This pocket card provides information on the treatment of drug-susceptible TB disease. The pocket card is adapted from the 2016 Official American Thoracic Society, Centers for Disease Control and Prevention, Infectious Disease Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.